Expression of the proliferation-associated Ki-67 antigen of transferrin receptors and of DNA polymerase? in human tumour lines: implications for in vitro chemoresistance
- 1 February 1992
- journal article
- research article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 118 (2) , 116-122
- https://doi.org/10.1007/bf01187499
Abstract
To compare the time course of in vitro expression of various proliferation-associated markers including Ki-67 antigen, transferrin receptors (TfR), and DNA polymerase α, six human tumour cell lines of different histological origin were studied under defined conditions. Proliferation markers were demonstrated by peroxidase/anti-peroxidase staining using specific monoclonal antibodies, and their expression was compared to results obtained from [3H]-thymidine incorporation assays and cell counting. Expression of all proliferation markers began to increase during the lag phase, and occurred earlier than elevations of [3H]dT incorporation and cell numbers were recorded. Maximum expression was observed before cell growth reached plateau phase. The time courses of expression of DNA polymerase and Ki-67 were almost identical. The closest correlation of [3H]dT incorporation with time course of expression of proliferation-associated markers was observed, when intranuclear staining of DNA polymerase was analysed. TfR were expressed earlier than the polymerase and Ki-67. Since TfR were also found at remarkable levels in resting cells, they seem less proliferation-specific than Ki-67 and DNA polymerase. While in rapidly growing cell lines more than 95% of the cells expressed Ki-67, TfR, and more than 75% DNA polymerase in cell nuclei, a malignant melanoma and a pleural mesothelioma line displayed fewer than 35% of cells stained for DNA polymerase in cell nuclei during log phase. Determination of growth fractions by monoclonal antibodies may thus contribute to the prediction of chemoresistance by identifying quiescent cells that are not sensitive to S-phasespecific drugs.Keywords
This publication has 26 references indexed in Scilit:
- Induction of multiple‐drug resistance during anti‐neoplastic chemotherapy in vitroInternational Journal of Cancer, 1991
- Effects of Reoxygenation on Cells From Hypoxic Regions of Solid Tumors: Anticancer Drug Sensitivity and Metastatic PotentialJNCI Journal of the National Cancer Institute, 1990
- Ki‐67 derived proliferative activity in colorectal adenocarcinoma with prognostic correlationsThe Journal of Pathology, 1988
- Immunohistological determination of proliferative activity in seminomas.Journal of Clinical Pathology, 1988
- Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variablesThe Journal of Pathology, 1987
- Colony assay with human tumor xenografts, murine tumors and human bone marrow. Potential for anticancer drug developmentEuropean Journal of Cancer and Clinical Oncology, 1987
- Simultaneous staining of exponentially growing versus plateau phase cells with the proliferation‐associated antibody Ki‐67 and propidium iodide: analysis by flow cytometryCell Proliferation, 1987
- Proliferative Activity of Human Solid Tumors Evaluated by Thymidine Labeling Index and Primer-Dependent α-DNA PolymeraseOncology, 1986
- An immunohistological method for estimating cell growth fractions in rapid histopathological diagnosis during surgeryInternational Journal of Cancer, 1985
- Development and Characterization of 51 Human Tumor Models for Large Bowel, Stomach and Esophageal CancersDigestive Surgery, 1984